Document is current
Any future updates will be listed below
-
Authors
Hammer, Daniella R. https://orcid.org/0000-0002-6241-4837
Voruz, François https://orcid.org/0000-0003-2774-5507
Aksit, Aykut https://orcid.org/0000-0003-4565-1205
Breil, Eugénie
Rousset, Francis https://orcid.org/0000-0001-7747-179X
Senn, Pascal https://orcid.org/0000-0002-4619-3341
Ilmjärv, Sten
Olson, Elizabeth S. https://orcid.org/0000-0002-3586-7769
Lalwani, Anil K. https://orcid.org/0000-0002-3823-3470
Kysar, Jeffrey W. https://orcid.org/0000-0003-3655-1077
-
Funding
Funding for this research was provided by:
National Science Foundation Graduate Research Fellowship (DGE-2036197)
United States Department of Defense Congressionally Directed Medical Research Programs (W81XWH22-1-0983, W81XWH22-1-0983, W81XWH22-1-0983, W81XWH22-1-0983, W81XWH22-1-0983, W81XWH22-1-0983, W81XWH22-1-0983)
Fondation Pour l’Audition (FPA RD-202202, FPA RD-202202, FPA RD-202202)
NIH/NCI Cancer Center Support Grant (P30CA013696, P30CA013696)
- License Information
-
More Information
Article History
Accepted: 12 May 2025
First Online: 10 June 2025
Declarations
: The Institutional Animal Care and Use Committee (IACUC) at Columbia University reviewed and approved all animal care and surgical procedures.
: Anil K. Lalwani, Jeffrey W. Kysar, and Aykut Aksit are co-founders of and have equity in Haystack Medical Inc., which aims to commercialize microneedle technology for treating hearing and balance disorders. Aykut Aksit is Chief Executive Officer of Haystack Medical Inc. (at the time of publication). Sten Ilmjärv is Head of Data Science at Antion Biosciences SA, specializing in developing therapeutics using cell and gene engineering. Daniella R. Hammer, François Voruz, Francis Rousset, Pascal Senn, Eugénie Breil, and Elizabeth S. Olson do not have financial nor non-financial relationships to disclose. A conflict-of-interest committee at Columbia University has reviewed and approved all documents.
